戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 or GLP-1-stimulated insulin secretion during perifusion.
2 nsion was recorded during continuous dynamic perifusion.
3 ed in vivo and in isolated islets ex vivo by perifusion.
4                          RESEARCH DESIGN AND Perifusion analyses of isolated Munc18c- (-/+) or Munc18
5                                              Perifusion analysis reveals that the second phase of glu
6                                        Islet perifusion and calcium imaging studies showed abnormal r
7                                        Islet perifusion and calcium-imaging studies showed abnormal r
8 nsulin secretion ability by in vitro glucose perifusion and explore the expression of insulin pathway
9                                              Perifusion assays using pancreatic islets from transgeni
10                                     Further, perifusion assays with human islets isolated from a dono
11                                     In islet perifusion assays, physiologic concentrations of leucine
12                                   In ex vivo perifusion assays, Smad3-deficient islets exhibit improv
13 e insulin secretion profile in dynamic islet perifusion assays.
14 ucose-stimulated insulin release response in perifusion assays.
15                                        Under perifusion conditions, high glucose concentrations induc
16 n from islets and beta cells under static or perifusion conditions, whereas an inactive structural an
17  glucose-stimulated insulin release in islet perifusion experiments and have significantly reduced pa
18                                              Perifusion experiments indicated that cPLA(2) underexpre
19                                              Perifusion experiments with human islets indicated that
20                                           In perifusion experiments with isolated islets in the absen
21                                           In perifusion experiments, acute insulin responses (AIRs) i
22  exhibit elevated insulin release in ex vivo perifusion experiments, during hyperglycemic clamps, and
23                                           In perifusion experiments, elevations in extracellular Ca2+
24 e studied using [Ca(2+)] imaging, static and perifusion insulin secretion assays, and gap junction pe
25                                 During islet perifusions, KIC and 2 mM glutamine caused robust dose-d
26                       During local CTX + APA perifusion, L-NNA + INDO abolished SCVD while conducted
27                      Low-Ca2+ or Ca(2+)-free perifusion medium induced oscillatory bursting activity
28 d currents (IPSCs) were usually blocked with perifusion of 10-50 microM bicuculline methiodide (BMI).
29 actional [3H]ACh release was recorded during perifusion of acutely dissociated, [3H]choline-labeled,
30                        However, simultaneous perifusion of explants with ATP (100 micrometer) and PE
31                                              Perifusion of fatty acids restored both responses.
32                    In the second experiment, perifusion of hypothalamic slices with 10(-8) or 10(-7)
33                                              Perifusion of neurexin-1alpha KO mouse islets revealed a
34                         In addition, ex vivo perifusion of recovered human islet grafts demonstrated
35                                              Perifusion of slices with 7.5-10 mM TEA, a K+ channel bl
36                                              Perifusion of slices with media containing 1-2 microM TT
37 failed to induce an IDAP-like current during perifusion of slices with media containing high [K+]o or
38                                              Perifusion of Syn-1A-betaKO islets showed impaired first
39           Surprisingly, insulin secretion in perifusion or static incubation experiments in response
40  measured every 20 min during a 3-h baseline perifusion period and after depolarization with 56 mM KC
41 functional capacity of islets as assessed by perifusion (r=0.60; P=0.022).
42 s was confirmed in vitro by pancreatic islet perifusion showing an amplified biphasic glucose-stimula
43                               Isolated islet perifusion studies demonstrated that exendin-(9-39) bloc
44                                        Islet perifusion studies failed to demonstrate abnormalities i
45                                              Perifusion studies indicate that the inhibition of [3H]p
46 e to glucose plus isobutyl-methylxanthine in perifusion studies that is clearly larger in magnitude t
47                                              Perifusion studies using pharmacologic inhibitors (genis
48 ycemic clamps, as well as isolated islet and perifusion studies.
49                                            A perifusion study revealed that leptin (50 ng/ml) affecte
50 elease obtained from the same islet lot in a perifusion system (n=12).
51                                      Using a perifusion system to follow secretion over time revealed
52 rent GnRH pulse frequencies using a parallel perifusion system.
53  The study of islets in static incubation or perifusion systems can be informative, but the normal pa
54 ch was cut into fine slices and subjected to perifusion to monitor glucagon release.
55 his response was not observed if the insulin perifusion was not switched off when the islets were dep
56            Similarly, in a third experiment, perifusion with 10(-7) M insulin caused a significant de
57                                              Perifusion with 16.7 mmol/l glucose plus 0.1 mmol/l IBMX
58                                              Perifusion with ATP before mechanical stimulation suppre
59                                 During local perifusion with KCa antagonists, iberiotoxin (5 microm)
60 kade of Ca2+ release from internal stores by perifusion with ryanodine or dantrolene, or direct diffu
61         Depletion of internal Ca2+ stores by perifusion with thapsigargin or cyclopiazonic acid also
62 n freshly isolated mouse acinar cells during perifusion with the bile acid taurolithocholic acid 3-su
63 ed pituitary cells and from cells undergoing perifusion with the peptides.